Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification

BACKGROUND: Adalimumab blocks the action of tumor necrosis factor-α and reduces disease progression in rheumatoid arthritis and psoriatic arthritis. The effects of adalimumab in controlling progression of structural damage in erosive hand osteoarthritis (HOA) were assessed. METHODS: Sixty patients w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Verbruggen, Gust, Wittoek, Ruth, Cruyssen, Bert Vander, Elewaut, Dirk
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2011
Soggetti:
Clinical and Epidemiological Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3371224/
https://ncbi.nlm.nih.gov/pubmed/22128078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.149849
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi